But f-circM9 (fusion circRNA MLL/AF9) was proved probably not sufficient to trigger tumorigenesis on its own, it plays an active role in favoring leukemia progression in vivo when coupled with other oncogenic stimuli (e.g., the presence of the oncogenic fusion protein) [82]. The gene discussed is KMT2A; the disease is leukemia.